LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Kodu・Aktsiate loetelu・Clover Health Investments Corp

Clover Health Investments Corp

Suletud

2.96 -17.32

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.59

Max

3.4699999999999998

Põhinäitajad
By Trading Economics
Sissetulek	-9.3M -11M
Müük	15M 478M
Kasumimarginaal	-2.215
Töötajad	570
EBITDA	-9.4M -10M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	-4.26% downside

Turustatistika
By TradingEconomics
Turukapital	420M 1.9B
Eelmine avamishind	20.28
Eelmine sulgemishind	2.96

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

3.4 / 3.77 Toetus ja vastupanu

Clover Health Investments Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. nov 2025, 23:51 UTC

Tulu

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5. nov 2025, 23:10 UTC

Tulu

DBS Third Quarter Net Dips 2.0%

5. nov 2025, 22:55 UTC

Tulu

Arm Holdings 2Q Profit Climbs on Record Demand

5. nov 2025, 22:23 UTC

Tulu

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5. nov 2025, 23:52 UTC

Tulu

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5. nov 2025, 23:49 UTC

Tulu

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5. nov 2025, 23:49 UTC

Tulu

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5. nov 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5. nov 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5. nov 2025, 23:12 UTC

Tulu

Nutrien 3Q Adj EPS 97c >NTR.T

5. nov 2025, 23:11 UTC

Tulu

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5. nov 2025, 23:10 UTC

Tulu

Nutrien 3Q Sales $6.01B >NTR.T

5. nov 2025, 23:10 UTC

Market Talk

Tulu

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5. nov 2025, 23:10 UTC

Tulu

Nutrien 3Q EPS 96c >NTR.T

5. nov 2025, 23:04 UTC

Tulu

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5. nov 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5. nov 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5. nov 2025, 22:55 UTC

Tulu

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5. nov 2025, 22:51 UTC

Tulu

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5. nov 2025, 22:50 UTC

Tulu

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5. nov 2025, 22:44 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5. nov 2025, 22:43 UTC

Market Talk

Tulu

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5. nov 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5. nov 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5. nov 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5. nov 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Responds to Delaware Chancery Court Ruling

5. nov 2025, 22:01 UTC

Tulu

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5. nov 2025, 22:01 UTC

Tulu

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Võrdlus sarnastega

Hinnamuutus

Clover Health Investments Corp Prognoos

Hinnasiht

By TipRanks

-4.26% langus

12 kuu keskmine prognoos

Keskmine 3.37 USD -4.26%

Kõrge 4.1 USD

Madal 3 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Clover Health Investments Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Clover Health Investments Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

3.4 / 3.77Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Clover Health Investments Corp

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.